Scarica l'app Stockscreener
65.73
1.84%
-1.23
Dopo l'orario di chiusura:
65.41
-0.32
-0.49%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$66.96
Aprire:
$67.42
Volume 24 ore:
7.35M
Relative Volume:
1.14
Capitalizzazione di mercato:
$25.64B
Reddito:
$4.30B
Utile/perdita netta:
$571.50M
Rapporto P/E:
46.01
EPS:
1.4285
Flusso di cassa netto:
$570.80M
1 W Prestazione:
+0.17%
1M Prestazione:
+13.21%
6M Prestazione:
-19.83%
1 anno Prestazione:
-14.85%
Intervallo 1D:
$65.36
$67.75
Intervallo di 1 settimana:
$64.40
$69.77
Portata 52W:
$54.11
$93.25
Dexcom Inc Stock (DXCM) Company Profile
Nome
Dexcom Inc
Settore
Industria
Telefono
(858) 200-0200
Indirizzo
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Confronta DXCM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
65.73 | 26.12B | 4.30B | 571.50M | 570.80M | 1.4285 |
|
ABT
Abbott Laboratories
|
128.47 | 218.16B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.19 | 137.24B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.31 | 135.41B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.57 | 128.03B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.38 | 48.21B | 5.88B | 1.34B | 799.60M | 2.3489 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | Iniziato | Evercore ISI | In-line |
| 2025-10-21 | Ripresa | Stifel | Buy |
| 2025-09-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-08-21 | Iniziato | Argus | Buy |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-05-30 | Iniziato | Goldman | Buy |
| 2025-04-10 | Iniziato | Mizuho | Outperform |
| 2025-02-03 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | Iniziato | Redburn Atlantic | Neutral |
| 2024-03-12 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-04-17 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2023-01-26 | Iniziato | Wolfe Research | Outperform |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-15 | Iniziato | Bernstein | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2021-10-18 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-28 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2021-01-06 | Aggiornamento | UBS | Neutral → Buy |
| 2020-10-02 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | Reiterato | Piper Sandler | Overweight |
| 2020-05-14 | Iniziato | Wells Fargo | Equal Weight |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-11-07 | Reiterato | Canaccord Genuity | Buy |
| 2019-11-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-10-23 | Iniziato | Stifel | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-09-12 | Aggiornamento | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | Reiterato | Canaccord Genuity | Buy |
| 2018-07-02 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-05-11 | Iniziato | BofA/Merrill | Buy |
| 2018-05-03 | Reiterato | Canaccord Genuity | Buy |
| 2018-04-04 | Iniziato | Goldman | Sell |
| 2018-04-04 | Iniziato | Guggenheim | Neutral |
| 2018-03-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | Downgrade | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | Reiterato | Wedbush | Outperform |
Mostra tutto
Dexcom Inc Borsa (DXCM) Ultime notizie
DXCM Deadline: DXCM Investors with Losses in Excess of $100K Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - Morningstar
Investors in DexCom, Inc. (DXCM): Protect Your RightsContact Levi & Korsinsky Before December 26, 2025 - Stockhouse
DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT Bernstein - GlobeNewswire
Shareholders of DexCom, Inc. (DXCM): Protect Your Rights Before December 26, 2025Contact Levi & Korsinsky - Stockhouse
DXCM CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Shareholders of Securities Fraud Class Action Lawsuit - PR Newswire
Castleark Management LLC Invests $27.18 Million in DexCom, Inc. $DXCM - MarketBeat
2025-12-13 | Levi & Korsinsky Notifies DexCom, Inc. (DXCM) Shareholders of Class Action Lawsuit and December 26, 2025 Deadline | NDAQ:DXCM | Press Release - Stockhouse
DXCM DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 29 Deadline in Securities Class Action – DXCM - GlobeNewswire Inc.
Jim Cramer on DexCom: "It's Too Rich a Stock" - Finviz
Jim Cramer on DexCom: “It’s too rich a stock” - MSN
Jim Cramer on DexCom: “It’s Too Rich a Stock” - Insider Monkey
Bellevue Group AG Cuts Holdings in DexCom, Inc. $DXCM - MarketBeat
Shareholders of DexCom, Inc. Should Contact Levi & - GlobeNewswire
Key facts: DexCom faces class action lawsuit; Citigroup raises price target - TradingView — Track All Markets
DexCom, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit - Business Wire
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SueWallSt Podcast Explains Class Action Against DexCom, Inc. (DXCM) - ACCESS Newswire
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
Citigroup Maintains DexCom (DXCM) Buy Recommendation - Nasdaq
DexCom Stock Surges 12%, With A 11-Day Winning Spree - Trefis
DexCom, Inc. Sued for Securities Law Violations – Investors - GlobeNewswire
DexCom (DXCM) Sees Buy Rating Maintained by Citigroup with Price - GuruFocus
Your Guide to the DexCom, Inc. LawsuitA SueWallSt Podcast From Levi & Korsinsky - ACCESS Newswire
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class ActionContact Lieff Cabraser - ACCESS Newswire
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. LawsuitDXCM - PR Newswire
Citigroup Adjusts DexCom Price Target to $77 From $75, Maintains Buy Rating - marketscreener.com
Frontier Capital Management Co. LLC Sells 35,907 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom Stock 10-Day Winning Spree: Stock Climbs 9.5% - Trefis
DXCM Deadline: DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - marketscreener.com
Levi & Korsinsky Releases SueWallSt Podcast on DexCom, Inc. (DXCM) Lawsuit - ACCESS Newswire
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Sirios Capital Management L P Boosts Stock Position in DexCom, Inc. $DXCM - MarketBeat
Natixis Has $5.47 Million Holdings in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Acquired by California Public Employees Retirement System - MarketBeat
Shareholders SueWallSt in New Class Action Against DexCom, Inc.Act Now - Nasdaq
DexCom Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
DexCom, Inc. (DXCM) Shareholders Get Answers in Latest SueWallSt Podcast - ACCESS Newswire
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Purchases Shares of 33,470 DexCom, Inc. $DXCM - MarketBeat
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bank of Nova Scotia Sells 400,824 Shares of DexCom, Inc. $DXCM - MarketBeat
2Xideas AG Sells 27,564 Shares of DexCom, Inc. $DXCM - MarketBeat
Here's How Much $100 Invested In DexCom 15 Years Ago Would Be Worth Today - Sahm
8-Day Rally Sends DexCom Stock Up 6.4% - Trefis
Shareholders that lost money on DexCom, Inc.(DXCM) Urged to - GlobeNewswire
DEXCOM, INC. (NASDAQ: DXCM) SHAREHOLDER ALERT Bernstein - GlobeNewswire
DexCom, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before December 26, 2025 to Discuss Your RightsDXCM - WV News
DexCom, Inc. $DXCM Shares Acquired by WINTON GROUP Ltd - MarketBeat
Dexcom Inc Azioni (DXCM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.60%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):